Literature DB >> 10758959

Independent association of serum squalene and noncholesterol sterols with coronary artery disease in postmenopausal women.

R A Rajaratnam1, H Gylling, T A Miettinen.   

Abstract

OBJECTIVES: The purpose of the study was to investigate whether cholesterol metabolism is associated with coronary artery disease (CAD) in postmenopausal women.
BACKGROUND: Although hypercholesterolemia, a predominant risk factor of CAD, is related to cholesterol metabolism, the association between cholesterol metabolism and CAD is not well known.
METHODS: In addition to conventional coronary risk factors, fasting serum squalene, delta8-cholestenol, desmosterol, lathosterol (indicators of cholesterol synthesis), cholestanol, campesterol and sitosterol (indicators of cholesterol absorption) were measured in 48 50- to 55-year-old consecutive women with angiographically verified CAD and in 61 age-matched healthy controls.
RESULTS: The coronary patients had elevated ratios of squalene (p < 0.001), desmosterol (p = 0.005), campesterol (p = 0.028) and sitosterol (p = 0.022) to cholesterol, but had lower respective lathosterol value (p = 0.041) compared with the controls, despite similar serum cholesterol levels. Adjusted for age, body mass index, family history of CAD, smoking, hypertension, serum triglycerides, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol level and glycosylated hemoglobin A1c% (GHbA1c), the ratios of squalene (odds ratio, 1.36; 95% confidence interval, 1.17 to 1.57), lathosterol (0.98; 0.97 to 0.99), campesterol (1.01; 1.00 to 1.01) and sitosterol (1.01; 1.00 to 1.03) were significantly associated with the risk of CAD. In addition, family history of CAD and GHbA1c% were also independently related to the presence of CAD.
CONCLUSIONS: The results suggest that women with elevated ratios of serum squalene, campesterol and sitosterol to cholesterol and low respective lathosterol values have enhanced risk for CAD. Thus, enhanced absorption and reduced synthesis of cholesterol may be related to coronary atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10758959     DOI: 10.1016/s0735-1097(00)00527-1

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  42 in total

Review 1.  Sitosterolemia--a rare disease. Are elevated plant sterols an additional risk factor?

Authors:  T Sudhop; K von Bergmann
Journal:  Z Kardiol       Date:  2004-12

2.  Clinical observations, molecular genetic analysis, and treatment of sitosterolemia in infants and children.

Authors:  Dau-Ming Niu; Kah-Wai Chong; Ju-Hui Hsu; Tina Jui-Ting Wu; Hsiao-Chi Yu; Cheng-Hung Huang; Ming-Yu Lo; Ching Fai Kwok; Lisa E Kratz; Low-Tone Ho
Journal:  J Inherit Metab Dis       Date:  2010-06-03       Impact factor: 4.982

3.  Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men.

Authors:  André J Tremblay; Benoît Lamarche; Valéry Lemelin; Lizbeth Hoos; Suzanne Benjannet; Nabil G Seidah; Harry R Davis; Patrick Couture
Journal:  J Lipid Res       Date:  2010-12-01       Impact factor: 5.922

Review 4.  Increased plasma levels of plant sterols and atherosclerosis: a controversial issue.

Authors:  Laura Calpe-Berdiel; Jesús Méndez-González; Francisco Blanco-Vaca; Joan Carles Escolà-Gil
Journal:  Curr Atheroscler Rep       Date:  2009-09       Impact factor: 5.113

5.  Plasma oxyphytosterol concentrations are not associated with CVD status in Framingham Offspring Study participants.

Authors:  Sabine Baumgartner; Rouyanne T Ras; Elke A Trautwein; Maurice C J M Konings; Ronald P Mensink; Jogchum Plat
Journal:  J Lipid Res       Date:  2019-08-27       Impact factor: 5.922

6.  The ABCG8 G574R variant, serum plant sterol levels, and cardiovascular disease risk in the Old Order Amish.

Authors:  Richard B Horenstein; Braxton D Mitchell; Wendy S Post; Dieter Lütjohann; Klaus von Bergmann; Kathleen A Ryan; Michael Terrin; Alan R Shuldiner; Nanette I Steinle
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-12-13       Impact factor: 8.311

7.  Phytosterol plasma concentrations and coronary heart disease in the prospective Spanish EPIC cohort.

Authors:  Verónica Escurriol; Montserrat Cofán; Concepción Moreno-Iribas; Nerea Larrañaga; Carmen Martínez; Carmen Navarro; Laudina Rodríguez; Carlos A González; Dolores Corella; Emilio Ros
Journal:  J Lipid Res       Date:  2009-09-28       Impact factor: 5.922

8.  Dietary phytosterols and phytostanols decrease cholesterol levels but increase blood pressure in WKY inbred rats in the absence of salt-loading.

Authors:  Qixuan Chen; Heidi Gruber; Eleonora Swist; Kara Coville; Catherine Pakenham; Walisundera Mn Ratnayake; Kylie A Scoggan
Journal:  Nutr Metab (Lond)       Date:  2010-02-12       Impact factor: 4.169

9.  Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers.

Authors:  Thomas M van Himbergen; Nirupa R Matthan; Nancy A Resteghini; Seiko Otokozawa; Masumi Ai; Evan A Stein; Peter H Jones; Ernst J Schaefer
Journal:  J Lipid Res       Date:  2008-11-30       Impact factor: 5.922

10.  Controversial role of plant sterol esters in the management of hypercholesterolaemia.

Authors:  Oliver Weingärtner; Michael Böhm; Ulrich Laufs
Journal:  Eur Heart J       Date:  2009-01-21       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.